. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: Depress Anxiety. 2017 Sep 29;34(12):1147–1156. doi: 10.1002/da.22681

Table 2.

Predicted Changes in Rates and Slopes in Antidepressant Prescription Fills Before and After FDA Boxed Warning, by Race/Ethnicity (n=249)

	White	Black		Latino
	Estimate (SE)	Estimate (SE)	Different from White	Estimate (SE)	Different from White

Baseline rate Jan 2002^†	229.29 (5.86)	66.16 (2.49)	^***	29.17 (2.40)	^***

Change in rate after warning^Δ	−66.80 (10.94)^***	−29.12 (4.59)^***	^***	−20.76 (4.42)^***	^***

Slope (Δ/month) before warning^‡	2.46 (0.45)^***	0.90 (0.19)^***	^***	0.86 (0.18)^***	^**

Slope (Δ/month) after warning^‡	−0.70 (0.10)^***	−0.11 (0.04)^**	^***	−0.07 (0.04)	^***

Change in slope	−3.16 (0.47)^***	−1.01 (0.20)^***	^***	−0.94 (0.19)^***	^***

p<0.05,

^**

p<0.01,

^***

p<0.001

^†

Rate is number of prescription fills/10,000 youth per month

^‡

Slope is monthly change in number of prescription fills/10,000 youth

^Δ

Change in rate is level shift between October 2003 and October 2004